Highlights

array(40) {
  [0]=>
  string(4) "8236"
  ["article_id"]=>
  string(4) "8236"
  [1]=>
  string(67) "Novavax Reports Fourth Quarter and Full Year 2019 Financial Results"
  ["article_title"]=>
  string(67) "Novavax Reports Fourth Quarter and Full Year 2019 Financial Results"
  [2]=>
  string(150) "GAITHERSBURG, Md., March  11, 2020  (GLOBE NEWSWIRE) --  Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation v"
  ["short_description"]=>
  string(150) "GAITHERSBURG, Md., March  11, 2020  (GLOBE NEWSWIRE) --  Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation v"
  [3]=>
  string(352) "

GAITHERSBURG, Md., March 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2019.

" ["description"]=> string(352) "

GAITHERSBURG, Md., March 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2019.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(138) "http://www.globenewswire.com/news-release/2020/03/11/1999049/0/en/Novavax-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results.html" ["blog_url"]=> string(138) "http://www.globenewswire.com/news-release/2020/03/11/1999049/0/en/Novavax-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results.html" [15]=> string(19) "2020-03-12 04:17:00" ["add_date"]=> string(19) "2020-03-12 04:17:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-12 15:55:50" ["create_at"]=> string(19) "2020-03-12 15:55:50" [19]=> string(0) "" ["slug"]=> string(0) "" }

Novavax Reports Fourth Quarter and Full Year 2019 Financial Results

GAITHERSBURG, Md., March 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late

array(40) {
  [0]=>
  string(4) "8268"
  ["article_id"]=>
  string(4) "8268"
  [1]=>
  string(77) "What the info blocking compliance timeline means for providers, vendors, HIEs"
  ["article_title"]=>
  string(77) "What the info blocking compliance timeline means for providers, vendors, HIEs"
  [2]=>
  string(154) "With a six-month reprieve before enforcement begins, healthcare organizations will soon have to "change their operating procedures to be in compliance"
  ["short_description"]=>
  string(154) "With a six-month reprieve before enforcement begins, healthcare organizations will soon have to "change their operating procedures to be in compliance"
  [3]=>
  string(174) "With a six-month reprieve before enforcement begins, healthcare organizations will soon have to "change their operating procedures to be in compliance," says ONC.&#nl"
  ["description"]=>
  string(174) "With a six-month reprieve before enforcement begins, healthcare organizations will soon have to "change their operating procedures to be in compliance," says ONC.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(105) "https://www.healthcareitnews.com/news/what-info-blocking-compliance-timeline-means-providers-vendors-hies"
  ["blog_url"]=>
  string(105) "https://www.healthcareitnews.com/news/what-info-blocking-compliance-timeline-means-providers-vendors-hies"
  [15]=>
  string(19) "2020-03-12 04:12:21"
  ["add_date"]=>
  string(19) "2020-03-12 04:12:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

What the info blocking compliance timeline means for providers, vendors, HIEs

With a six-month reprieve before enforcement begins, healthcare organizations will soon have to "change their operat

array(40) {
  [0]=>
  string(4) "8269"
  ["article_id"]=>
  string(4) "8269"
  [1]=>
  string(68) "Health systems adopt zero trust approach to secure networks, devices"
  ["article_title"]=>
  string(68) "Health systems adopt zero trust approach to secure networks, devices"
  [2]=>
  string(174) ""Zero trust flips the security model: Instead of 'trust but verify,' organizations 'always verify but never trust,'" one security expert explains.&#nl"
  ["short_description"]=>
  string(174) ""Zero trust flips the security model: Instead of 'trust but verify,' organizations 'always verify but never trust,'" one security expert explains.&#nl"
  [3]=>
  string(174) ""Zero trust flips the security model: Instead of 'trust but verify,' organizations 'always verify but never trust,'" one security expert explains.&#nl"
  ["description"]=>
  string(174) ""Zero trust flips the security model: Instead of 'trust but verify,' organizations 'always verify but never trust,'" one security expert explains.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(102) "https://www.healthcareitnews.com/news/health-systems-adopt-zero-trust-approach-secure-networks-devices"
  ["blog_url"]=>
  string(102) "https://www.healthcareitnews.com/news/health-systems-adopt-zero-trust-approach-secure-networks-devices"
  [15]=>
  string(19) "2020-03-12 03:52:12"
  ["add_date"]=>
  string(19) "2020-03-12 03:52:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Health systems adopt zero trust approach to secure networks, devices

"Zero trust flips the security model: Instead of 'trust but verify,' organizations 'always verify but ne

array(40) {
  [0]=>
  string(4) "8221"
  ["article_id"]=>
  string(4) "8221"
  [1]=>
  string(51) "Ophthalmologic Symptoms Common in Parkinson Disease"
  ["article_title"]=>
  string(51) "Ophthalmologic Symptoms Common in Parkinson Disease"
  [2]=>
  string(150) "WEDNESDAY, March 11, 2020 -- Patients with Parkinson disease (PD) have a higher prevalence of ophthalmologic symptoms than controls, according to a st"
  ["short_description"]=>
  string(150) "WEDNESDAY, March 11, 2020 -- Patients with Parkinson disease (PD) have a higher prevalence of ophthalmologic symptoms than controls, according to a st"
  [3]=>
  string(250) "WEDNESDAY, March 11, 2020 -- Patients with Parkinson disease (PD) have a higher prevalence of ophthalmologic symptoms than controls, according to a study published online March 11 in Neurology.&#nlCarlijn D.J.M. Borm, M.D., from Radboud University..."
  ["description"]=>
  string(250) "WEDNESDAY, March 11, 2020 -- Patients with Parkinson disease (PD) have a higher prevalence of ophthalmologic symptoms than controls, according to a study published online March 11 in Neurology.&#nlCarlijn D.J.M. Borm, M.D., from Radboud University..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(164) "https://www.drugs.com/news/ophthalmologic-common-parkinson-88888.html?utm_source=ddc&utm_medium=rss&utm_campaign=Ophthalmologic+Symptoms+Common+in+Parkinson+Disease"
  ["blog_url"]=>
  string(164) "https://www.drugs.com/news/ophthalmologic-common-parkinson-88888.html?utm_source=ddc&utm_medium=rss&utm_campaign=Ophthalmologic+Symptoms+Common+in+Parkinson+Disease"
  [15]=>
  string(19) "2020-03-12 03:00:48"
  ["add_date"]=>
  string(19) "2020-03-12 03:00:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Ophthalmologic Symptoms Common in Parkinson Disease

WEDNESDAY, March 11, 2020 -- Patients with Parkinson disease (PD) have a higher prevalence of ophthalmologic symptoms th

array(40) {
  [0]=>
  string(4) "8222"
  ["article_id"]=>
  string(4) "8222"
  [1]=>
  string(35) "WHO Declares Coronavirus a Pandemic"
  ["article_title"]=>
  string(35) "WHO Declares Coronavirus a Pandemic"
  [2]=>
  string(157) "WEDNESDAY, March 11, 2020 -- The World Health Organization on Wednesday officially declared the coronavirus outbreak sweeping the globe a pandemic.&#nl"W"
  ["short_description"]=>
  string(157) "WEDNESDAY, March 11, 2020 -- The World Health Organization on Wednesday officially declared the coronavirus outbreak sweeping the globe a pandemic.&#nl"W"
  [3]=>
  string(252) "WEDNESDAY, March 11, 2020 -- The World Health Organization on Wednesday officially declared the coronavirus outbreak sweeping the globe a pandemic.&#nl"WHO has been assessing this outbreak around the clock and we are deeply concerned both by the..."
  ["description"]=>
  string(252) "WEDNESDAY, March 11, 2020 -- The World Health Organization on Wednesday officially declared the coronavirus outbreak sweeping the globe a pandemic.&#nl"WHO has been assessing this outbreak around the clock and we are deeply concerned both by the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(146) "https://www.drugs.com/news/declares-coronavirus-pandemic-88887.html?utm_source=ddc&utm_medium=rss&utm_campaign=WHO+Declares+Coronavirus+a+Pandemic"
  ["blog_url"]=>
  string(146) "https://www.drugs.com/news/declares-coronavirus-pandemic-88887.html?utm_source=ddc&utm_medium=rss&utm_campaign=WHO+Declares+Coronavirus+a+Pandemic"
  [15]=>
  string(19) "2020-03-12 03:00:23"
  ["add_date"]=>
  string(19) "2020-03-12 03:00:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:50:34"
  ["create_at"]=>
  string(19) "2020-03-12 15:50:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

WHO Declares Coronavirus a Pandemic

WEDNESDAY, March 11, 2020 -- The World Health Organization on Wednesday officially declared the coronavirus outbreak swe

array(40) {
  [0]=>
  string(4) "8264"
  ["article_id"]=>
  string(4) "8264"
  [1]=>
  string(88) "Proposed Legislation Targets a Critical Regulatory-Reimbursement Gap for Medical Devices"
  ["article_title"]=>
  string(88) "Proposed Legislation Targets a Critical Regulatory-Reimbursement Gap for Medical Devices"
  [2]=>
  string(153) "&#nlReggie Dye went 15 years without seeing a physician, in part because he had always been incredibly healthy. He regularly does high-intens"
  ["short_description"]=>
  string(153) "&#nlReggie Dye went 15 years without seeing a physician, in part because he had always been incredibly healthy. He regularly does high-intens"
  [3]=>
  string(5358) "&#nl

Reggie Dye went 15 years without seeing a physician, in part because he had always been incredibly healthy. He regularly does high-intensity worksouts, enjoys hiking, golf, and can't remember the last time he even had a cold. But a preventative health evaluation incentive program his company offered in 2016 taught him that even the healthiest individuals are not immune to prostate cancer.

&#nl

After two prostate-specific antigen (PSA) screening tests, followed by additional testing, Dye was diagnosed with localized prostate cancer. At first, he was given the choice of active surveillance, also known as "watchful waiting" or more aggressive treatment options such as radiation, cryotherapy, and surgery – all of which are associated with unpleasant side effects, including incontinence and impotence. Then he learned about high intensity focused ultrasound (HIFU).

&#nl

Dye was a candidate for HIFU because he had a low-grade cancer that hand not spread outside the prostate gland. He found it to be an attractive treatment option because the risks of "those dreaded side effects" are much lower, he said, and because he is aware that African-American men are twice as likely to die from prostate cancer than white men.

&#nl

"After I first got my diagnosis, I contacted my brother and sent an email to my black fraternity brothers telling them to get their PSA tests," Dye said. "They were stunned because they knew me to be someone in good shape with no medical issues. I'm glad to say, they took my advice and got their checkups. One even invited a physician to speak to the men at his church about prostate cancer."

&#nl

HIFU works by heating up sound waves to ablate diseased tissue. MRI imaging focused with biopsy data and image-guided ultrasound allow urologists to target only the diseased portion of the prostate and leave surrounding nerve structures intact – reducing the risk of unwanted side effects.

&#nl

While HIFU presents an attractive option for men like Dye, not all candidates for HIFU can actually afford to go through with it because the procedure is not covered by private insurers and only partially reimbursed by the Centers for Medicare and Medicaid Services (CMS), and even then only for patients who are 65 or older.

&#nl

On Monday, Dye and two other African-American men who have been successfully treated for prostate cancer with HIFU met with members of Congress to share their stories and push a new legislation that could help HIFU and other novel medical technologies become more accessible for patients who can't afford to pay out of pocket. The proposed legislation, dubbed the New Opportunities for Value That Extends Lives (NOVEL) Act, aims to provide expedited reimbursement coding and provesional coverage for medical devices that have been approved via FDA's relatively new breakthrough device designation pathway, and modify current approval and reimbursement pathways.

&#nl

"One of the big challenges that medical device manufacturers face is that gap between FDA approval and CMS coding coverage and reimbursement and this is the first legislation that we've really seen that addresses that gap," Holly Grosholz, manager of goverment relations at the Medical Imaging Technology Association, told MD+DI during a recent interview. "... We see this as a step in the right direction for innovative devices and future iterations of focused ultrasound ... anything that provide oppties for innovat devices like fu to be available and accessible to patients sooner is our priority."

&#nl

Jessica Foley, chief scientific officer at the Focused Ultrasound Foundation, told MD+DI that HIFU is currently being investigated for the treatment of over 130 diff clinical applications, prostate cancer being one of them and many other cancers but also a lot of neurological disorders such as essential tremor and Parkinson's disease.

&#nl

Before the development and FDA approval of HIFU, many urologists encouraged the watchful waiting approach because of how invasive other treatment options were. For some low-risk prostate cancer patients, that may still be the best course, and obviously not all men with prostate cancer are good candidates for HIFU, so treatment recommendations continue to be highly indivdualized.

&#nl

"The alternative to watchful waiting now doesn't have to be a full-on major surgery, now it can be something much less invasive so I think that makes it much more appealing for patients," Foley said.

" ["description"]=> string(5358) "&#nl

Reggie Dye went 15 years without seeing a physician, in part because he had always been incredibly healthy. He regularly does high-intensity worksouts, enjoys hiking, golf, and can't remember the last time he even had a cold. But a preventative health evaluation incentive program his company offered in 2016 taught him that even the healthiest individuals are not immune to prostate cancer.

&#nl

After two prostate-specific antigen (PSA) screening tests, followed by additional testing, Dye was diagnosed with localized prostate cancer. At first, he was given the choice of active surveillance, also known as "watchful waiting" or more aggressive treatment options such as radiation, cryotherapy, and surgery – all of which are associated with unpleasant side effects, including incontinence and impotence. Then he learned about high intensity focused ultrasound (HIFU).

&#nl

Dye was a candidate for HIFU because he had a low-grade cancer that hand not spread outside the prostate gland. He found it to be an attractive treatment option because the risks of "those dreaded side effects" are much lower, he said, and because he is aware that African-American men are twice as likely to die from prostate cancer than white men.

&#nl

"After I first got my diagnosis, I contacted my brother and sent an email to my black fraternity brothers telling them to get their PSA tests," Dye said. "They were stunned because they knew me to be someone in good shape with no medical issues. I'm glad to say, they took my advice and got their checkups. One even invited a physician to speak to the men at his church about prostate cancer."

&#nl

HIFU works by heating up sound waves to ablate diseased tissue. MRI imaging focused with biopsy data and image-guided ultrasound allow urologists to target only the diseased portion of the prostate and leave surrounding nerve structures intact – reducing the risk of unwanted side effects.

&#nl

While HIFU presents an attractive option for men like Dye, not all candidates for HIFU can actually afford to go through with it because the procedure is not covered by private insurers and only partially reimbursed by the Centers for Medicare and Medicaid Services (CMS), and even then only for patients who are 65 or older.

&#nl

On Monday, Dye and two other African-American men who have been successfully treated for prostate cancer with HIFU met with members of Congress to share their stories and push a new legislation that could help HIFU and other novel medical technologies become more accessible for patients who can't afford to pay out of pocket. The proposed legislation, dubbed the New Opportunities for Value That Extends Lives (NOVEL) Act, aims to provide expedited reimbursement coding and provesional coverage for medical devices that have been approved via FDA's relatively new breakthrough device designation pathway, and modify current approval and reimbursement pathways.

&#nl

"One of the big challenges that medical device manufacturers face is that gap between FDA approval and CMS coding coverage and reimbursement and this is the first legislation that we've really seen that addresses that gap," Holly Grosholz, manager of goverment relations at the Medical Imaging Technology Association, told MD+DI during a recent interview. "... We see this as a step in the right direction for innovative devices and future iterations of focused ultrasound ... anything that provide oppties for innovat devices like fu to be available and accessible to patients sooner is our priority."

&#nl

Jessica Foley, chief scientific officer at the Focused Ultrasound Foundation, told MD+DI that HIFU is currently being investigated for the treatment of over 130 diff clinical applications, prostate cancer being one of them and many other cancers but also a lot of neurological disorders such as essential tremor and Parkinson's disease.

&#nl

Before the development and FDA approval of HIFU, many urologists encouraged the watchful waiting approach because of how invasive other treatment options were. For some low-risk prostate cancer patients, that may still be the best course, and obviously not all men with prostate cancer are good candidates for HIFU, so treatment recommendations continue to be highly indivdualized.

&#nl

"The alternative to watchful waiting now doesn't have to be a full-on major surgery, now it can be something much less invasive so I think that makes it much more appealing for patients," Foley said.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "40" ["rss_id"]=> string(2) "40" [14]=> string(109) "https://www.mddionline.com/proposed-legislation-targets-critical-regulatory-reimbursement-gap-medical-devices" ["blog_url"]=> string(109) "https://www.mddionline.com/proposed-legislation-targets-critical-regulatory-reimbursement-gap-medical-devices" [15]=> string(19) "2020-03-12 02:52:34" ["add_date"]=> string(19) "2020-03-12 02:52:34" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-12 15:56:14" ["create_at"]=> string(19) "2020-03-12 15:56:14" [19]=> string(0) "" ["slug"]=> string(0) "" }

Proposed Legislation Targets a Critical Regulatory-Reimbursement Gap for Medical Devices

array(40) {
  [0]=>
  string(4) "8275"
  ["article_id"]=>
  string(4) "8275"
  [1]=>
  string(48) "DRE Health Plans Mask Manufacturing Plant in U.S"
  ["article_title"]=>
  string(48) "DRE Health Plans Mask Manufacturing Plant in U.S"
  [2]=>
  string(158) "&#nl        KANSAS CITY, MO — DRE Health Corporation, a Missouri-based manufacturer, wholesaler, distributor, and retailer of medical equipment, instru"
  ["short_description"]=>
  string(158) "&#nl        KANSAS CITY, MO — DRE Health Corporation, a Missouri-based manufacturer, wholesaler, distributor, and retailer of medical equipment, instru"
  [3]=>
  string(375) "&#nl        KANSAS CITY, MO — DRE Health Corporation, a Missouri-based manufacturer, wholesaler, distributor, and retailer of medical equipment, instruments, and supplies plans to build a manufacturing plant for disposable face masks in the United States in response to the recent global Coronavirus outbreak, along with a disposable glove production plant. &#nl      "
  ["description"]=>
  string(375) "&#nl        KANSAS CITY, MO — DRE Health Corporation, a Missouri-based manufacturer, wholesaler, distributor, and retailer of medical equipment, instruments, and supplies plans to build a manufacturing plant for disposable face masks in the United States in response to the recent global Coronavirus outbreak, along with a disposable glove production plant. &#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(90) "https://www.assemblymag.com/articles/95522-dre-health-plans-mask-manufacturing-plant-in-us"
  ["blog_url"]=>
  string(90) "https://www.assemblymag.com/articles/95522-dre-health-plans-mask-manufacturing-plant-in-us"
  [15]=>
  string(19) "2020-03-12 02:15:54"
  ["add_date"]=>
  string(19) "2020-03-12 02:15:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:42"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

DRE Health Plans Mask Manufacturing Plant in U.S

&#nl KANSAS CITY, MO — DRE Health Corporation, a Missouri-based manufacturer, wholesaler, distributor, and

array(40) {
  [0]=>
  string(4) "8266"
  ["article_id"]=>
  string(4) "8266"
  [1]=>
  string(75) "I resist pressure to work long hours — but my coworkers don’t"
  ["article_title"]=>
  string(75) "I resist pressure to work long hours — but my coworkers don’t"
  [2]=>
  string(150) "A reader writes: I’m hoping to get some advice on fending off pressure and comments to fall in line and work unpaid overtime. I work a public jo"
  ["short_description"]=>
  string(150) "A reader writes: I’m hoping to get some advice on fending off pressure and comments to fall in line and work unpaid overtime. I work a public jo"
  [3]=>
  string(1449) "

A reader writes: I’m hoping to get some advice on fending off pressure and comments to fall in line and work unpaid overtime. I work a public job in the health sector. I have really good boundaries about taking my breaks and lunch and leaving when my shift is done. However, it seems like there’s […]

&#nl&#nl

I resist pressure to work long hours — but my coworkers don’t was originally published by Alison Green on Ask a Manager.

&#nl" ["description"]=> string(1449) "

A reader writes: I’m hoping to get some advice on fending off pressure and comments to fall in line and work unpaid overtime. I work a public job in the health sector. I have really good boundaries about taking my breaks and lunch and leaving when my shift is done. However, it seems like there’s […]

&#nl&#nl

I resist pressure to work long hours — but my coworkers don’t was originally published by Alison Green on Ask a Manager.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "5" ["category"]=> string(1) "5" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "50" ["rss_id"]=> string(2) "50" [14]=> string(99) "https://www.askamanager.org/2020/03/i-resist-pressure-to-work-long-hours-but-my-coworkers-dont.html" ["blog_url"]=> string(99) "https://www.askamanager.org/2020/03/i-resist-pressure-to-work-long-hours-but-my-coworkers-dont.html" [15]=> string(19) "2020-03-12 01:59:39" ["add_date"]=> string(19) "2020-03-12 01:59:39" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-12 15:56:19" ["create_at"]=> string(19) "2020-03-12 15:56:19" [19]=> string(0) "" ["slug"]=> string(0) "" }

I resist pressure to work long hours — but my coworkers don’t

A reader writes: I’m hoping to get some advice on fending off pressure and comments to fall in line and work un

array(40) {
  [0]=>
  string(4) "8270"
  ["article_id"]=>
  string(4) "8270"
  [1]=>
  string(55) "Key resources to keep track of the coronavirus pandemic"
  ["article_title"]=>
  string(55) "Key resources to keep track of the coronavirus pandemic"
  [2]=>
  string(137) "Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread of COVID-19.&#nl"
  ["short_description"]=>
  string(137) "Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread of COVID-19.&#nl"
  [3]=>
  string(137) "Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread of COVID-19.&#nl"
  ["description"]=>
  string(137) "Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread of COVID-19.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(83) "https://www.healthcareitnews.com/news/key-resources-keep-track-coronavirus-pandemic"
  ["blog_url"]=>
  string(83) "https://www.healthcareitnews.com/news/key-resources-keep-track-coronavirus-pandemic"
  [15]=>
  string(19) "2020-03-12 01:52:25"
  ["add_date"]=>
  string(19) "2020-03-12 01:52:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Key resources to keep track of the coronavirus pandemic

Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread

array(40) {
  [0]=>
  string(4) "8271"
  ["article_id"]=>
  string(4) "8271"
  [1]=>
  string(64) "Jvion debuts AI-powered social determinants of health technology"
  ["article_title"]=>
  string(64) "Jvion debuts AI-powered social determinants of health technology"
  [2]=>
  string(150) "The new system, developed with Microsoft Azure, is designed to help healthcare organizations align community resources to identify gaps and social bar"
  ["short_description"]=>
  string(150) "The new system, developed with Microsoft Azure, is designed to help healthcare organizations align community resources to identify gaps and social bar"
  [3]=>
  string(168) "The new system, developed with Microsoft Azure, is designed to help healthcare organizations align community resources to identify gaps and social barriers to care.&#nl"
  ["description"]=>
  string(168) "The new system, developed with Microsoft Azure, is designed to help healthcare organizations align community resources to identify gaps and social barriers to care.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(99) "https://www.healthcareitnews.com/news/jvion-debuts-ai-powered-social-determinants-health-technology"
  ["blog_url"]=>
  string(99) "https://www.healthcareitnews.com/news/jvion-debuts-ai-powered-social-determinants-health-technology"
  [15]=>
  string(19) "2020-03-12 01:05:12"
  ["add_date"]=>
  string(19) "2020-03-12 01:05:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Jvion debuts AI-powered social determinants of health technology

The new system, developed with Microsoft Azure, is designed to help healthcare organizations align community resources t

array(40) {
  [0]=>
  string(4) "8265"
  ["article_id"]=>
  string(4) "8265"
  [1]=>
  string(62) "New Financing Could Help BillionToOne Expand Product Offerings"
  ["article_title"]=>
  string(62) "New Financing Could Help BillionToOne Expand Product Offerings"
  [2]=>
  string(153) "&#nlBillionToOne wants to expand its diagnostic offerings and its most recent financing could give it a push in that direction. The Menlo Park, CA-based "
  ["short_description"]=>
  string(153) "&#nlBillionToOne wants to expand its diagnostic offerings and its most recent financing could give it a push in that direction. The Menlo Park, CA-based "
  [3]=>
  string(2222) "&#nl

BillionToOne wants to expand its diagnostic offerings and its most recent financing could give it a push in that direction. The Menlo Park, CA-based company has raised $15 million in a follow-on to its series A round.

&#nl

With this financing, the company BillionToOne has brought in more than $32.5 million. The private company noted previous investors, Hummingbird Ventures and NeoTribe Ventures led the investment round with participation from Y Combinator, Libertus Capital, Pacific 8 Ventures, Civilization Ventures, 500 Startups Istanbul, and HOF Capital.

&#nl

BillionToOne said it will use the proceeds to support the commercial expansion of Unity to all states as well as the research and development (R&D) of future diagnostics tests including liquid biopsy products.

&#nl

Unity is a non-invasive prenatal screen test (NIPT) that directly assesses the baby's risk for common and severe inherited disorders such as cystic fibrosis, spinal muscular atrophy (SMA), and hemoglobinopathies from a single tube of blood from the pregnant mother.

&#nl

"Since the launch of Unity last summer, we faced a significant demand from the prenatal providers from community Ob/Gyns to top academic institutions throughout the US,” Oguzhan Atay, PhD, co-founder and CEO of BillionToOne, said in a release. “We are planning to expand the capacity of our CLIA-licensed laboratory by more than 20 times and our commercial team size up to 50 account executives to meet the demand.”

&#nl

Unity could face some pretty stiff competition in the NIPT market. In 2018 Qiagen, which is now in the process of being acquired by Thermo Fisher Scientific for $11.5 billion, jumped into the NIPT space. Qiagen was able to do this through a $40 million collaboration with Natera.

" ["description"]=> string(2222) "&#nl

BillionToOne wants to expand its diagnostic offerings and its most recent financing could give it a push in that direction. The Menlo Park, CA-based company has raised $15 million in a follow-on to its series A round.

&#nl

With this financing, the company BillionToOne has brought in more than $32.5 million. The private company noted previous investors, Hummingbird Ventures and NeoTribe Ventures led the investment round with participation from Y Combinator, Libertus Capital, Pacific 8 Ventures, Civilization Ventures, 500 Startups Istanbul, and HOF Capital.

&#nl

BillionToOne said it will use the proceeds to support the commercial expansion of Unity to all states as well as the research and development (R&D) of future diagnostics tests including liquid biopsy products.

&#nl

Unity is a non-invasive prenatal screen test (NIPT) that directly assesses the baby's risk for common and severe inherited disorders such as cystic fibrosis, spinal muscular atrophy (SMA), and hemoglobinopathies from a single tube of blood from the pregnant mother.

&#nl

"Since the launch of Unity last summer, we faced a significant demand from the prenatal providers from community Ob/Gyns to top academic institutions throughout the US,” Oguzhan Atay, PhD, co-founder and CEO of BillionToOne, said in a release. “We are planning to expand the capacity of our CLIA-licensed laboratory by more than 20 times and our commercial team size up to 50 account executives to meet the demand.”

&#nl

Unity could face some pretty stiff competition in the NIPT market. In 2018 Qiagen, which is now in the process of being acquired by Thermo Fisher Scientific for $11.5 billion, jumped into the NIPT space. Qiagen was able to do this through a $40 million collaboration with Natera.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "40" ["rss_id"]=> string(2) "40" [14]=> string(89) "https://www.mddionline.com/new-financing-could-help-billiontoone-expand-product-offerings" ["blog_url"]=> string(89) "https://www.mddionline.com/new-financing-could-help-billiontoone-expand-product-offerings" [15]=> string(19) "2020-03-12 00:44:30" ["add_date"]=> string(19) "2020-03-12 00:44:30" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-12 15:56:14" ["create_at"]=> string(19) "2020-03-12 15:56:14" [19]=> string(0) "" ["slug"]=> string(0) "" }

New Financing Could Help BillionToOne Expand Product Offerings

array(40) {
  [0]=>
  string(4) "8272"
  ["article_id"]=>
  string(4) "8272"
  [1]=>
  string(78) "Sentinel Healthcare debuts quarantine management platform for coronavirus, flu"
  ["article_title"]=>
  string(78) "Sentinel Healthcare debuts quarantine management platform for coronavirus, flu"
  [2]=>
  string(150) "The remote-monitoring technology is designed to help health systems and employers monitor, evaluate risk, and provide real-time escalation alerts for "
  ["short_description"]=>
  string(150) "The remote-monitoring technology is designed to help health systems and employers monitor, evaluate risk, and provide real-time escalation alerts for "
  [3]=>
  string(196) "The remote-monitoring technology is designed to help health systems and employers monitor, evaluate risk, and provide real-time escalation alerts for individuals exposed to infectious disease.&#nl"
  ["description"]=>
  string(196) "The remote-monitoring technology is designed to help health systems and employers monitor, evaluate risk, and provide real-time escalation alerts for individuals exposed to infectious disease.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(111) "https://www.healthcareitnews.com/news/sentinel-healthcare-debuts-quarantine-management-platform-coronavirus-flu"
  ["blog_url"]=>
  string(111) "https://www.healthcareitnews.com/news/sentinel-healthcare-debuts-quarantine-management-platform-coronavirus-flu"
  [15]=>
  string(19) "2020-03-11 23:37:03"
  ["add_date"]=>
  string(19) "2020-03-11 23:37:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:22"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Sentinel Healthcare debuts quarantine management platform for coronavirus, flu

The remote-monitoring technology is designed to help health systems and employers monitor, evaluate risk, and provide re